DURECT Corp - Company Profile
Powered by 
All the data and insights you need on DURECT Corp in one report.
$295
- Save hours of research time and resources with
our up-to-date DURECT Corp Strategy Report
- Understand DURECT Corp position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
DURECT Corp (Durect) is a biopharmaceutical company that focuses on the research and development of new chemical entities for the treatment of acute organ injury and chronic liver diseases based on its endogenous epigenetic regulator program. The company’s major product pipeline comprises DUR-928, indicated for the treatment of alcoholic hepatitis and nonalcoholic steatohepatitis (NASH); Posimir, indicated to treat post-operative pain; and Oradur, indicated for chronic pain and attention deficit hyperactivity disorders. Durect also manufactures and sells osmotic pumps for laboratory research; and offers standard and custom biodegradable polymers and excipients for customers in pharmaceutical and medical device industry. The company operates in the US, Europe, Japan and other countries. Durect is headquartered in Cupertino, California, the US.
Headquarters
United States of America
Address
10240 Bubb Road, Cupertino, California, 95014
Website
www.durect.com
Telephone
1 408 7771417
No of Employees
58
Industry
Medical Equipment
Ticker Symbol & Exchange
DRRX (NASD)
Revenue (2022)
$8.5M
-55.7%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
21.8%
(2022 vs 2021)
Market Cap*
$26.2M
Net Profit Margin (2022)
XYZ
-76.4%
(2022 vs 2021)
* As of and is in US$
DURECT Corp premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Osmotic Pump | Posidur |
| Biodegradable Polymer | Saber |
| Pipeline | Cloud |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
Competitor Comparison
| Key Parameters | DURECT Corp | AbbVie Inc | AstraZeneca Plc | Eli Lilly and Co | Medtronic Plc |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United Kingdom | United States of America | Ireland |
| City | Cupertino | North Chicago | Cambridge | Indianapolis | Dublin |
| State/Province | California | Illinois | England | Indiana | - |
| No. of Employees | 58 | 50,000 | 89,900 | 43,000 | 95,000 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Gail Maderis | Chairman | Executive Board | 2023 | - |
| James E. Brown, D.V.M. | Chief Executive Officer; Director; President | Executive Board | 1998 | 66 |
| Timothy M. Papp, M.B.A. | Chief Financial Officer | Senior Management | 2022 | 47 |
| Norman L. Sussman, M.D., FAASLD | Chief Medical Officer | Senior Management | 2020 | 69 |
| Jian Li, M.B.A. | Vice President - Finance; Controller | Senior Management | 2003 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward